We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fonebak | LSE:FON | London | Ordinary Share | GB00B06GNN57 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.02 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMRGS
RNS Number : 7407Z
Regenersis PLC
22 September 2015
22 September 2015
REGENERSIS PLC
("Regenersis")
DIRECTORS' DECLARATIONS
Regenersis Plc (AIM:RGS.L, "Regenersis", the "Group") is pleased to announce the following Board appointments from 1 October 2015:
Ian Donald Powell will join the main Board as Executive Director in the role of CEO of Aftermarket Services. Mr Powell, age 54, was previously Group Managing Director of Regenersis in the period 2011-2013, prior to that he has been CEO of Chapelthorpe plc, and Chairman Chairman/Chief Executive of several businesses where he held material equity stakes. In the last 5 years, Mr Powell has held the following Directorships:
Current directorships Past directorships Tangram Ventures Limited Chapelthorpe plc ------------------- Tangram Trading Inc -------------------
Patrick J Clawson will join the main Board as Executive Director as CEO of Digital Security Software. Mr Clawson, aged 51, was previously Chairman/CEO of Lumension, a US endpoint security software business. In the last 5 years, Mr Clawson has held the following Directorships:
Current directorships Past directorships Blancco OY Limited Cyberguard Inc ------------------- Xcaliber Technologies LLC Lumension Inc ------------------- K is for Kids Foundation -------------------
Thomas Kevin Skelton will join the main Board as Non Executive Director. Mr Skelton, aged 54, is the current CEO of Surescripts, a market leading software business which enables over six billion annual e-prescriptions and other healthcare transactions in the USA. Until recently, he had been a non-executive director of Micro Focus International Plc since 2006. Mr Skelton has no current shareholding or share option or incentive plan awards in Regenersis.
Current directorships Past directorships Surescripts LLC Microfocus International Plc -----------------------------
Regenersis confirms that there are no further disclosures required in accordance with paragraph (g) of Schedule Two, AIM Rules for Companies.
Enquiries:
Regenersis Plc +44 (0) 20 3657 7000
Matthew Peacock, Executive Chairman
Jog Dhody, Chief Financial Officer
Peel Hunt LLP (Nomad and Joint Broker) +44 (0) 20 7418 8900
Richard Kauffer
Edward Fox
Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500
Charles Leigh Pemberton
Tulchan Communications +44 (0) 20 7353 4200
Tom Murray
Victoria Huxster
Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology.
www.regenersis.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOADBGDCSDDBGUB
(END) Dow Jones Newswires
September 22, 2015 02:02 ET (06:02 GMT)
1 Year Fonebak Chart |
1 Month Fonebak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions